EBAG9 and neoplasm: Other downregulated genes, such as HARS, UBXN1, EBAG9 and SGK1, reduce cytotoxic activity of T lymphocytes, block tumor T cell infiltration, drive T helper type 2 differentiation (TH2) or memory differentiation in CD8 T cells when expression is lost.